Accelerates screening of customized CRISPR and shRNA libraries Eliminates need for resource-intensive in-house assay development and screening Billerica, Massachusetts — MilliporeSigma today announced that it has entered into a set of agreements with Evotec AG, whereby Evotec AG will provide screening services for MilliporeSigma’s collection of genetic reagents such as CRISPR and shRNA […]
The TriStar2 S LB 942 and Mithras2 LB 943 Multimode Readers from Berthold Technologies have been granted Transcreener® HTS assay certification for running Bellbrook Lab’s Transcreener® TR-FRET and FI assays. The Transcreener® HTS assay platform is a universal, high throughput biochemical assay class based on the direct detection of nucleotides formed by cellular enzymes. Many […]
– Collaboration on a validated CRISPR platform and Merck’s extensive genomic toolkits beyond CRISPR – Integration of Evotec’s expertise on phenotypic screening and disease biology Hamburg, Germany: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the signing of a set of collaboration agreements with the life science business of Merck, which will combine […]
SANTA CRUZ, Calif. — SomaGenics, an RNA-focused biotechnology company, announced expansion of its intellectual property portfolio with issue of two new patents for its RNA analysis technologies (miR-ID® and RealSeq®) and European patent protection for its therapeutic short synthetic hairpin RNA (sshRNA) agents. MiR-ID®, SomaGenics’ core technology for quantitative real-time PCR, enables accurate analysis of […]
ROCKVILLE, Md. — Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, announced today that the company has entered into a definitive agreement to acquire the assets of Omnia Biologics, Inc. (Omnia), including Omnia’s cGMP facility and equipment. The financial terms of the transaction were not disclosed. The assets acquired by […]
CARLSBAD, Calif. Thermo Fisher Scientific, the world leader in serving science, today announced it has signed a purchase agreement to acquire MTI-GlobalStem, a privately-held company that develops and commercializes leading-edge technology and reagents for cell transfection, neurobiology and stem cell research applications. Completion of the transaction follows the receipt of all required regulatory approvals. Per […]
Uppsala, Sweden – Olink Proteomics today announced the launch of three new precision proteomics panels, significantly expanding its library of high quality human protein biomarker assays, from 460 to over 700. This series of new panels is designed to enable scientists to extend their discovery capabilities for studying the plasma proteome by casting a broader […]
With this agreement, effective January 1, 2017, select Epicentre products will be manufactured and sold exclusively by Lucigen Corporation directly to customers and through its distribution network worldwide. Epicentre Technologies, known for its genomics and transcriptomics products for gene expression, cloning, and in vitro transcription, was acquired by Illumina in 2011, and continues to operate as a wholly owned […]
Dr. Peter Robinson Recognized for Contributions to Clinical Genomics and Computational Biology SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Peter Robinson, M.D., MSC, has received an Agilent Thought Leader Award in recognition of his contributions to clinical genomics and computational biology. The award includes funding that will enable Dr. Robinson to […]
Granted patents confirm innovation and novelty of proteomics product range Strengthens OEM deals and non-exclusive out licensing possibilities Enhences competitive edge supporting expansion Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced it had been granted broad patents in Europe and China. The patent granted […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
